276 related articles for article (PubMed ID: 30401823)
1. Epigenetic profiling for the molecular classification of metastatic brain tumors.
Orozco JIJ; Knijnenburg TA; Manughian-Peter AO; Salomon MP; Barkhoudarian G; Jalas JR; Wilmott JS; Hothi P; Wang X; Takasumi Y; Buckland ME; Thompson JF; Long GV; Cobbs CS; Shmulevich I; Kelly DF; Scolyer RA; Hoon DSB; Marzese DM
Nat Commun; 2018 Nov; 9(1):4627. PubMed ID: 30401823
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Classifiers for Precision Diagnosis of Brain Tumors.
Orozco JI; Manughian-Peter AO; Salomon MP; Marzese DM
Epigenet Insights; 2019; 12():2516865719840284. PubMed ID: 30968063
[TBL] [Abstract][Full Text] [Related]
3. Brain metastasis DNA methylomes, a novel resource for the identification of biological and clinical features.
Salomon MP; Orozco JIJ; Wilmott JS; Hothi P; Manughian-Peter AO; Cobbs CS; Scolyer RA; Hoon DSB; Marzese DM
Sci Data; 2018 Nov; 5():180245. PubMed ID: 30398472
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations.
Marzese DM; Scolyer RA; Roqué M; Vargas-Roig LM; Huynh JL; Wilmott JS; Murali R; Buckland ME; Barkhoudarian G; Thompson JF; Morton DL; Kelly DF; Hoon DS
Neuro Oncol; 2014 Nov; 16(11):1499-509. PubMed ID: 24968695
[TBL] [Abstract][Full Text] [Related]
5. RASSF6 exhibits promoter hypermethylation in metastatic melanoma and inhibits invasion in melanoma cells.
Mezzanotte JJ; Hill V; Schmidt ML; Shinawi T; Tommasi S; Krex D; Schackert G; Pfeifer GP; Latif F; Clark GJ
Epigenetics; 2014 Nov; 9(11):1496-503. PubMed ID: 25482183
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide methylation analyses identifies Non-coding RNA genes dysregulated in breast tumours that metastasise to the brain.
Pangeni RP; Olivaries I; Huen D; Buzatto VC; Dawson TP; Ashton KM; Davis C; Brodbelt AR; Jenkinson MD; Bièche I; Yang L; Latif F; Darling JL; Warr TJ; Morris MR
Sci Rep; 2022 Jan; 12(1):1102. PubMed ID: 35058523
[TBL] [Abstract][Full Text] [Related]
7. Global DNA demethylation as an epigenetic marker of human brain metastases.
Barciszewska AM
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30254100
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.
Chatterjee A; Stockwell PA; Ahn A; Rodger EJ; Leichter AL; Eccles MR
Oncotarget; 2017 Jan; 8(4):6085-6101. PubMed ID: 28030832
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatic Strategies for the Genomic and Epigenomic Characterization of Brain Tumors.
Ramaswamy V; Taylor MD
Methods Mol Biol; 2019; 1869():37-56. PubMed ID: 30324512
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis.
Conway K; Edmiston SN; Parker JS; Kuan PF; Tsai YH; Groben PA; Zedek DC; Scott GA; Parrish EA; Hao H; Pearlstein MV; Frank JS; Carson CC; Wilkerson MD; Zhao X; Slater NA; Moschos SJ; Ollila DW; Thomas NE
J Invest Dermatol; 2019 Jun; 139(6):1349-1361. PubMed ID: 30529013
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation profiling of distant breast cancer metastases.
Schrijver WA; Jiwa LS; van Diest PJ; Moelans CB
Breast Cancer Res Treat; 2015 May; 151(1):41-55. PubMed ID: 25841351
[TBL] [Abstract][Full Text] [Related]
12. Network assessment of demethylation treatment in melanoma: Differential transcriptome-methylome and antigen profile signatures.
Jiang Z; Cinti C; Taranta M; Mattioli E; Schena E; Singh S; Khurana R; Lattanzi G; Tsinoremas NF; Capobianco E
PLoS One; 2018; 13(11):e0206686. PubMed ID: 30485296
[TBL] [Abstract][Full Text] [Related]
13. Integrated genomic and epigenomic analysis of breast cancer brain metastasis.
Salhia B; Kiefer J; Ross JT; Metapally R; Martinez RA; Johnson KN; DiPerna DM; Paquette KM; Jung S; Nasser S; Wallstrom G; Tembe W; Baker A; Carpten J; Resau J; Ryken T; Sibenaller Z; Petricoin EF; Liotta LA; Ramanathan RK; Berens ME; Tran NL
PLoS One; 2014; 9(1):e85448. PubMed ID: 24489661
[TBL] [Abstract][Full Text] [Related]
14. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
[TBL] [Abstract][Full Text] [Related]
15. Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns.
Harbst K; Staaf J; Måsbäck A; Olsson H; Ingvar C; Vallon-Christersson J; Ringnér M; Borg A; Jönsson G
Melanoma Res; 2010 Oct; 20(5):381-91. PubMed ID: 20848731
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of tumor suppressor genes in serum of patients with cutaneous melanoma.
Marini A; Mirmohammadsadegh A; Nambiar S; Gustrau A; Ruzicka T; Hengge UR
J Invest Dermatol; 2006 Feb; 126(2):422-31. PubMed ID: 16374457
[TBL] [Abstract][Full Text] [Related]
17. Profile of epigenetic mechanisms in lung tumors of patients with underlying chronic respiratory conditions.
Mateu-Jimenez M; Curull V; Rodríguez-Fuster A; Aguiló R; Sánchez-Font A; Pijuan L; Gea J; Barreiro E
Clin Epigenetics; 2018; 10():7. PubMed ID: 29371906
[TBL] [Abstract][Full Text] [Related]
18. High frequency of p16(INK4A) promoter methylation in NRAS-mutated cutaneous melanoma.
Jonsson A; Tuominen R; Grafström E; Hansson J; Egyhazi S
J Invest Dermatol; 2010 Dec; 130(12):2809-17. PubMed ID: 20703244
[TBL] [Abstract][Full Text] [Related]
19. Epigenomic landscape of melanoma progression to brain metastasis: unexplored therapeutic alternatives.
Marzese DM; Witz IP; Kelly DF; Hoon DS
Epigenomics; 2015; 7(8):1303-11. PubMed ID: 26638944
[TBL] [Abstract][Full Text] [Related]
20. Using epigenomics data to predict gene expression in lung cancer.
Li J; Ching T; Huang S; Garmire LX
BMC Bioinformatics; 2015; 16 Suppl 5(Suppl 5):S10. PubMed ID: 25861082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
